
IASLC/LinkedIn
Sep 2, 2025, 08:58
Chunxia Su Leads Virtual Tumor Board on Locally Advanced NSCLC – IASLC
International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:
“On a new episode of Lung Cancer Considered, Dr. Chunxia Su leads a Virtual Tumor Board discussion in Mandarin with Drs. Zhengfei Zhu and Nan Wu. Together, they explore key considerations in neoadjuvant and perioperative therapy for locally advanced NSCLC in China.
This episode is part of IASLC’s world language podcast series and brings expert insight to lung cancer treatment strategies in Mandarin.
More posts featuring IASLC on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2025, 10:11
Sep 2, 2025, 10:02
Sep 2, 2025, 09:56
Sep 2, 2025, 09:42
Sep 2, 2025, 09:40
Sep 2, 2025, 09:20
Sep 2, 2025, 09:11
Sep 2, 2025, 08:58